TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biomedola AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
89
|
105
|
87 |
| Financial expenses |
6
|
0
|
0 |
| Earnings before taxes |
129
|
74
|
67 |
| EBITDA |
43
|
70
|
67 |
| Total assets |
538
|
455
|
406 |
| Current assets |
348
|
279
|
230 |
| Current liabilities |
17
|
19
|
13 |
| Equity capital |
494
|
407
|
366 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.8%
|
89.5%
|
90.1% |
| Turnover per employee |
89
|
105
|
87 |
| Profit as a percentage of turnover |
144.9%
|
70.5%
|
77.0% |
| Return on assets (ROA) |
25.1%
|
16.3%
|
16.5% |
| Current ratio |
2047.1%
|
1468.4%
|
1769.2% |
| Return on equity (ROE) |
26.1%
|
18.2%
|
18.3% |
| Change turnover |
-13
|
18
|
17 |
| Change turnover % |
-13%
|
21%
|
24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.